Whether targeting iASPP can restore p53 tumor suppressor functions and how epigenetic mechanisms, such as aberrant microRNA (miRNA) expression, regulate iASPP expression in CC remains unclear. The gene discussed is PPP1R13L; the disease is neoplasm.